Dermata Therapeutics Inc. Common Stock (DRMA)
Stock · NASDAQ · Health Care
$1.49as of 8/28/2026
Price chart
Open in TradingViewDermata Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- DRMADermata Therapeutics Inc. Common Stock$1.49▲ 1.71%Market cap $4.46MP/E —
- RNAZTransCode Therapeutics Inc. Common Stock$2.18▼ 4.39%Market cap $4.52MP/E —$3.21$20.99
- REVBRevelation Biosciences Inc. Common Stock$1.05▲ 1.94%Market cap $4.38MP/E 0.04$0.875$11.6
- JUNSJupiter Neurosciences Inc. Common Stock$4.59▼ 6.13%Market cap $4.24MP/E —$4.1$138
- PPCBPropanc Biopharma Inc. Common Stock$1.4▼ 37.22%Market cap $4.76MP/E —$0.95$85.5
- INMInMed Pharmaceuticals Inc. Common Shares$1.43▼ 0.35%Market cap $4.01MP/E —$0.575$2.5
- MBIOMustang Bio Inc. Common Stock$0.5375▼ 2.27%Market cap $3.87MP/E —$0.525$1.85
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DRMA Dermata Therapeutics Inc. Common Stock | $4.46M | — | $1.49 | ▲ 1.71% | |
| RNAZ TransCode Therapeutics Inc. Common Stock | $4.52M | — | $2.18 | ▼ 4.39% | $3.21$20.99 |
| REVB Revelation Biosciences Inc. Common Stock | $4.38M | 0.04 | $1.05 | ▲ 1.94% | $0.875$11.6 |
| JUNS Jupiter Neurosciences Inc. Common Stock | $4.24M | — | $4.59 | ▼ 6.13% | $4.1$138 |
| PPCB Propanc Biopharma Inc. Common Stock | $4.76M | — | $1.4 | ▼ 37.22% | $0.95$85.5 |
| INM InMed Pharmaceuticals Inc. Common Shares | $4.01M | — | $1.43 | ▼ 0.35% | $0.575$2.5 |
| MBIO Mustang Bio Inc. Common Stock | $3.87M | — | $0.5375 | ▼ 2.27% | $0.525$1.85 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Institutional Ownership
March 31, 2026
- Total shares held
- 106.5K
- Total value held
- $128.9K
- Institutional holders
- 7
Top holders this quarter
- Unknown48.3K
- Unknown35.6K
- Unknown20.0K
- Unknown1.7K
- Unknown716
- Unknown101
- Unknown1
See the full, filterable feed with live charts on the MarketWall dashboard.